Cutler Group’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5
Closed -$1K 4836
2018
Q3
$1K Buy
+5
New +$4.61K ﹤0.01% 3947
2018
Q1
Sell
-81
Closed -$1K 5534
2017
Q4
$1K Sell
81
-4
-5% -$3.69K ﹤0.01% 4672
2017
Q3
$6K Sell
85
-95
-53% -$108K ﹤0.01% 4290
2017
Q2
$17K Sell
180
-25
-12% -$30.4K ﹤0.01% 3617
2017
Q1
$50K Sell
205
-91
-31% -$87.8K ﹤0.01% 2418
2016
Q4
$109K Buy
+296
New +$134K ﹤0.01% 1839
2016
Q2
Sell
-61
Closed -$2K 7531
2016
Q1
$2K Sell
61
-20
-25% -$7.73K ﹤0.01% 5744
2015
Q4
$12K Buy
+81
New +$56.7K ﹤0.01% 3977

Other funds holding HSTO

Cutler Group's HSTO Position: Q2 2019 in Review

Cutler Group sold out of Histogen Inc. Common Stock (HSTO) in Q2 2019, closing a stake of 44 shares — an estimated $9K sold.

Cutler Group first reported a position in HSTO in Q4 2015 and held it in 14 quarters. The position peaked at $128K in Q2 2017. 36 funds tracked by Wall St. Rank hold HSTO as of Q2 2019.

  • Cutler Group reported no remaining Histogen Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Cutler Group sold 44 Histogen Inc. Common Stock shares in Q2 2019, an estimated $9K.
  • Cutler Group first reported a position in Histogen Inc. Common Stock in Q4 2015 and held it in 14 quarters.
  • Cutler Group's Histogen Inc. Common Stock position peaked at $128K in Q2 2017.
  • 36 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2019.

Based on Cutler Group's 13F filing for Q2 2019, filed 9 Aug 2019.